Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Bettegazzi
Observed names:
BETTEGAZZI B,
Bettegazzi, B
Institutions:
Vita-Salute San Raffaele University,
IRCCS Ospedale San Raffaele
Observed institutions:
Vita-Salute San Raffaele University,
University of Milan,
Italian Institute of Technology,
IRCCS Ospedale San Raffaele,
IRCCS San Raffaele Roma,
Ludwig-Maximilians-Universität München
show all 6
ORCID:
0000-0001-5842-105X
Observed ORCID:
0000-0001-5842-105X
OpenAlex ID:
A5000207843
NPY and Gene Therapy for Epilepsy: How, When,... and Y
2021
·
Stefano Cattaneo
, Gianluca Verlengia
, et al.
·
Frontiers in Molecular Neuroscience
·
75
PDF
Dysfunctional Autophagy and Endolysosomal System in Neurodegenerative Diseases: Relevance and Therapeutic Options
2020
·
Silvia Giovedì
, Margherita Maria Ravanelli
, et al.
·
Frontiers in Cellular Neuroscience
·
55
PDF
Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model
2018
·
Tommaso Vannocci
, Roberto Notario Manzano
, et al.
·
Disease Models & Mechanisms
·
37
PDF
Ceruloplasmin potentiates nitric oxide synthase activity and cytokine secretion in activated microglia
2014
·
Massimo Lazzaro
, Barbara Bettegazzi
, et al.
·
Journal of Neuroinflammation
·
33
PDF
β-Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression
2010
·
Barbara Bettegazzi
, Marija Mihailovich
, et al.
·
European Journal of Neuroscience
·
31
eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathology
2017
·
Barbara Bettegazzi
, Serena Bellani
, et al.
·
Scientific Reports
·
29
PDF
Casein Kinase 2 dependent phosphorylation of eIF4B regulates BACE1 expression in Alzheimer’s disease
2021
·
Barbara Bettegazzi
, Laura Sebastian Monasor
, et al.
·
Cell Death and Disease
·
23
PDF
BACE1 Expression and Activity: Relevance in Alzheimer’s Disease
2007
·
Daniele Zacchetti
, Evelina Chieregatti
, et al.
·
Neurodegenerative Diseases
·
22
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold?
2023
·
Barbara Bettegazzi
, Stefano Cattaneo
, et al.
·
Molecular Diagnosis & Therapy
·
21
PDF
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development
2022
·
Annunziata Guarino
, Barbara Bettegazzi
, et al.
·
Neurotherapeutics
·
21
PDF
Redox and Calcium Alterations of a Müller Cell Line Exposed to Diabetic Retinopathy-Like Environment
2022
·
Clarissa Rosato
, Barbara Bettegazzi
, et al.
·
Frontiers in Cellular Neuroscience
·
20
PDF
Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential
2025
·
Cristina Porcari
, Stefano Cattaneo
, et al.
·
Frontiers in Physiology
·
18
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells
2024
·
Stefano Cattaneo
, Barbara Bettegazzi
, et al.
·
EMBO Reports
·
17
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells
2021
·
Marie Soukupová
, Silvia Zucchini
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
16
PDF
Gα13 Contributes to LPS-Induced Morphological Alterations and Affects Migration of Microglia
2021
·
Barbara Bettegazzi
, Serena Bellani
, et al.
·
Molecular Neurobiology
·
14
Upregulation of Peroxiredoxin 3 Protects Afg3l2-KO Cortical Neurons In Vitro from Oxidative Stress: A Paradigm for Neuronal Cell Survival under Neurodegenerative Conditions
2019
·
Barbara Bettegazzi
, Ilaria Pelizzoni
, et al.
·
Oxidative Medicine and Cellular Longevity
·
11
PDF
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus
2025
·
Barbara Terzic
, Esbjörn Melin
, et al.
·
Molecular Therapy
·
8
Altered Ca2+ responses and antioxidant properties in Friedreich's ataxia-like cerebellar astrocytes
2024
·
Chiara Marullo
, Laura Croci
, et al.
·
Journal of Cell Science
·
8
PDF
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility
2022
·
Federica Esposito
, Ana Maria Osiceanu
, et al.
·
Genes
·
7
PDF
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation
2024
·
Nimra Aziz
, Chiara Ruzza
, et al.
·
International Journal of Molecular Sciences
·
5
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
2025
·
Stefano Cattaneo
, Barbara Bettegazzi
, et al.
·
Gene Therapy
·
4
PDF
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays
2024
·
Chiara Sturaro
, Chiara Ruzza
, et al.
·
European Journal of Pharmacology
·
1
P3‐352: Beta‐secretase modulation and amyloid‐beta production in rat brain primary cultures
2008
·
Daniele Zacchetti
, Barbara Bettegazzi
, et al.
·
Alzheimer s & Dementia
·
1
Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
2026
·
Stefano Cattaneo
, Barbara Bettegazzi
, et al.
·
Gene Therapy
PDF
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and Mitophagy
2025
·
Daniela Lufrano
, Chunmei Gong
, et al.
·
Molecular Neurobiology
Show more works
View as search
Works count:
30
Citation count:
477
H-index:
14
I10-index:
16
Year
Topic
Type